Original Articles

Systemic Manifestations of RSV-Bronchiolitis Beyond the Lungs

  1. FGPC Hospital
  2. Department of Paediatric Medicine, Federal Government Polyclinic Hospital, Islamabad
  3. Khyber Medical University, Peshawar
https://doi.org/10.48036/09m0k065

Abstract

Objective: To evaluate the extrapulmonary manifestations in infants and young children admitted with PCR- confirmed RSV bronchiolitis and to examine their relationship with clinical acuity and in-hospital outcomes.

Methodology: A prospective observational study was carried out in the Department of Pediatrics, Federal Government Polyclinic Hospital, Islamabad from November 2025 to February 2026.  in children aged 1-48 months with PCR-confirmed RSV bronchiolitis. Patients with other viral or bacterial co-infection or chronic medical conditions were excluded. They were assessed for neurological, cardiovascular, gastrointestinal, and metabolic manifestations during hospitalization. The demographic data, clinical observations, laboratory values, level of care, respiratory support, the length of hospital stay, and outcomes were documented. Because a validated bronchiolitis severity score was not prospectively recorded, level of care was used as a pragmatic measure of clinical acuity; ward admission represented lower-acuity care and HDU/ICU admission higher-acuity care. The analysis of data was performed in SPSS 24, and the p-value < 0.05 was considered significant.

Results: A total of 123 pediatric patients with RSV-bronchiolitis were enrolled. Extrapulmonary findings were observed with metabolic manifestations in 29.3% patients followed by gastrointestinal(27.6%), neurological(26.7%) and cardiovascular[A1] [D2] [HN3] (21%) involvement. Metabolic manifestations included hypocalcemia(15.4%), hyponatremia(9.8%), hypokalemia(8.1%), hyperkalemia(7.3%) and hypernatremia(0.8%). Gastrointestinal involvement was in the form of diarrhea(11%) and vomiting(9%). Neurological problems included seizures(18%) and altered level of consciousness(8%). Cardiovascular manifestations included myocarditis(11%), murmur(9%) and tachycardia(1%). The mean duration of hospital stay was 6.2±3.7 days. The average hospital stay was significantly longer among patients with cardiac manifestations, including tachycardia (9.14±6.6 days), murmurs (6.18±3.0 days), and myocarditis (7.0±0.0 days), compared with those without cardiac involvement (5.8±3.0 days; p=0.020). However, no significant difference in hospital stay was observed in patients with gastrointestinal (p=0.127) and neurological manifestations (p=0.127). In severity-stratified analysis, any extrapulmonary manifestation occurred in 59.6% of ward patients and 70.6% of HDU/ICU patients (p=0.302); no individual system showed a statistically significant difference between the two groups. Amongst the six recorded deaths, 50% of patients had associated metabolic derangements.

Conclusion: RSV bronchiolitis demonstrates substantial multisystem involvement in hospitalized children with PCR-confirmed RSV bronchiolitis which were not confined to patients requiring HDU/ICU care. Cardiovascular involvement was associated with a longer hospital stay, while no statistically significant severity-based difference was demonstrated for individual extrapulmonary systems. Early recognition of these extrapulmonary manifestations is crucial to improve clinical outcome and optimize treatment.

Metrics

0Abstract views
0Downloads

License

Copyright (c) 2026 Hina Naveed, Rabia Tabassum, Naveed Ashraf, Awais Abid, Abdul Salam Wazir, Shahzad Munir, Maham Zahid

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by-nc/4.0/.) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

More in this Issue